It is a pharma private limited company based in Ahmadabad, Gujarat, India, established in 2020.
2020 | Ahmadabad, Gujarat, India | ActivePharmakem Formulation Private Limited, a active private limited company, was established on 21 December 2020 in Ahmadabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299GJ2020PTC118990. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Atul Ratilal Panara (Director), Meet Atul Panara (Director), Prem Divyesh Jagani (Director). Past directors included Vishwajitsinh Jatubha Rana, Jatubha Amarsinh Rana. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 79-Ghuma-89- Shriji Baug, Vi-Ghuma, Dascroi, Vill- Ahmadabad, Ahmadabad, Gujarat, 380058.
U24299GJ2020PTC118990
118990
21 December 2020
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Pharmakem Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atul Ratilal Panara | Director | 28 Jun 2021 | Current |
| Meet Atul Panara | Director | 28 Jun 2021 | Current |
| Prem Divyesh Jagani | Director | 21 Dec 2020 | Current |
| Divyesh Valjibhai Jagani | Director | 21 Dec 2020 | Current |
| Anjanaben Jagani | Director | 21 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 May 2023 | Past |
| Pramod Abcsdd | Director | 15 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmakem Formulation Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 866%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Pharmakem Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Pharmakem Formulation has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pharmakem Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmakem Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Pharmakem Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Pharmakem Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on Atul Ratilal Panara was appointed as a Director was appointed as a Director on 28 Jun 2021 & has been associated with this company since 4 years 5 months . was documented.
Progress on Meet Atul Panara was appointed as a Director was appointed as a Director on 28 Jun 2021 & has been associated with this company since 4 years 5 months . was documented.
Progress on Prem Divyesh Jagani was appointed as a Director was appointed as a Director on 21 Dec 2020 & has been associated with this company since 4 years 11 months . was documented.
Progress on Divyesh Valjibhai Jagani was appointed as a Director was appointed as a Director on 21 Dec 2020 & has been associated with this company since 4 years 11 months . was documented.
The CIN of Pharmakem Formulation Private Limited is U24299GJ2020PTC118990.
Pharmakem Formulation Private Limited is headquartered at 79-Ghuma-89- Shriji Baug, Vi-Ghuma, Dascroi, Vill- Ahmadabad, Ahmadabad, Gujarat, 380058.
Pharmakem Formulation Private Limited was incorporated on 21 December 2020.
The current directors of Pharmakem Formulation Private Limited are
The primary industry of Pharmakem Formulation Private Limited is Manufacturing.
Pharmakem Formulation Private Limited is unlisted.
The authorized capital of Pharmakem Formulation Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX